Visit https://www.peervoice.com/ZFC860 to view the entire programme with slides. After completing “Mapping New Blueprints for Lung Cancer Care: Congress Updates in NSCLC and ES-SCLC”, participants will be able to: Evaluate the latest evidence for the adjuvant treatment of EGFR-mutated non-small-cell lung cancer (NSCLC); and Outline key updates on the use of immunotherapy in the management of extensive-stage small cell lung cancer (ES-SCLC).